BIOMAT Database Logo BIOMAT Database Logo

Biochemical and immunochemical analysis of gangliosides of human small cell lung carcinoma: production of monoclonal antibodies against a unique marker of small cell lung carcinoma, ganglioside Fuc GM1. 1988

B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Institute of Human Morphology, USSR Academy of Medical Sciences, Moscow.

Immunization of mice with a pure preparation of the ganglioside adsorbed on Salmonella typhimurium and hybridization of splenocytes with myeloma P3-X63-Ag 8.653 have resulted in hybridomas producing monoclonal antibodies against ganglioside Fuc GM1, a marker of human small cell lung carcinoma. Characterization of four hybridomal clones and data on the antigenic specificity of the monoclonal antibodies are given. All four monoclonal antibodies reacted only with Fuc GM1 in an enzyme-linked immunosorbent assay. In radioimmunodetection of the antigen on thin-layer plates, two of the four monoclonal antibodies gave cross-reactions with Fuc GD1b. The obtained monoclonal antibodies have revealed the presence of Fuc GM1 in all seven cases of small cell lung carcinoma we have studied and the absence of Fuc GM1 in the normal human lung tissue and in lung adenocarcinomas.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1.
February 1986, Biochimica et biophysica acta,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
[Small cell carcinoma of the bladder. Small cell lung cancer-associated ganglioside (Fuc GM1) expression].
December 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
November 1994, Journal of biochemistry,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1.
March 1986, Cancer research,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Specificity and structure of murine monoclonal antibodies against GM1 ganglioside.
November 1994, Journal of neuroimmunology,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
January 1993, Acta oncologica (Stockholm, Sweden),
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Tumor-cell killing by MAbs against fucosyl GM1, a ganglioside antigen associated with small-cell lung carcinoma.
December 1991, International journal of cancer,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Monoclonal antibodies against two human lung carcinoma cell lines.
November 1982, British journal of cancer,
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.
April 2000, Lung cancer (Amsterdam, Netherlands),
B B Fuchs, and N F Avrova, and N A Starosvetskaya, and M N Boltovskaya, and E I Zaraisky, and O B Karpova, and E V Reznikova, and L N Soldatova, and A A Stepanov
Immunohistological detection of fucosyl-GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies.
March 1989, Cancer research,
Copied contents to your clipboard!